Omixon is an IT company specialized in bioinformatics, cheminformatics, computational chemistry and image processing. Omixon develops and offers biocomputing solutions on field programmable gate array (FPGA).
FPGAs have been used since the early 1990-s and represent the fastest-growing segment of the semiconductor industry. FPGA recently became accepted as an accelerator for computationally demanding scientific algorithms and both AMD and Intel support the close coupling of it with their CPUs.
With the use of FPGA Omixon can provide software support which significantly decreases the costs and duration of data analysis. The company offers products and custom applications primarily to chemical and pharmaceutical companies.
The product prototypes can be tested through a web interface.